BARCLAYS PLC

Position in GALT — Galectin Therapeutics Inc

CIK 312069 LONDON, X0

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,716

-$258,339 QoQ

Shares Held

11,577

-89.6% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 98 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. GALT ranks #276 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,716	11,577	-89.6%	Shares	Defined	2026-08-14
2026-03-31	$312,055	111,848	+5.1%	Shares	Defined	2026-05-15
2025-12-31	$442,627	106,401	+1040.9%	Shares	Sole	2026-02-13
2025-03-31	$11,377	9,326	-82.9%	Shares	Sole	2026-03-17
2024-12-31	$70,476	54,634	+91.1%	Shares	Sole	2026-03-19
2024-09-30	$78,614	28,587	+309.0%	Shares	Sole	2026-03-31
2024-06-30	$15,795	6,989	+190.4%	Shares	Sole	2026-03-23
2021-09-30	$9,339	2,407	-63.6%	Shares	Sole	2021-11-09
2021-06-30	$21,142	6,607	-78.8%	Shares	Sole	2021-08-13
2021-03-31	$67,473	31,094	+159.0%	Shares	Sole	2021-05-13
2020-12-31	$26,893	12,006	-30.5%	Shares	Sole	2021-02-11
2020-09-30	$46,137	17,280	-17.9%	Shares	Sole	2020-11-12
2020-06-30	$64,415	21,051	+57.3%	Shares	Sole	2020-08-12
2020-03-31	$26,228	13,382	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.